| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-07 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C303-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C269-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C303-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C37-055
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C39-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B53-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C213-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C309-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C213-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C37-002
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B61-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B53-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C311-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C39-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C269-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C213-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C303-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C311-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C309-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C215-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C271-44 |
| filingDate |
2009-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2012-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2012513966-A |
| titleOfInvention |
Process for the preparation of optically active compounds using hydrogen transfer reactions |
| abstract |
Contact methods for the preparation of optically active compounds and their subsequent conversion to the desired drug substance. In particular, this method relates to the preparation of (S) -3- (1-dimethylamino-ethyl) -phenol using asymmetric catalytic reduction and hydrogen transfer reactions, such as rivastigmine and rivastigmine hydrogen tartrate. Provide an improved route to form drug substance. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2014200094-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014200094-A1 |
| priorityDate |
2008-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |